Categories
Blood Cancer

My Life with Cancer – Hairy Cell Leukemia [Video]

My Life with Cancer – Hairy Cell Leukemia

It’s a long video but I had a lot to say today. I put this video together so that others can understand what I’ve been through. I also put it together for those that have or might be affected by this rare blood cancer. What I’ve learned through my journey is that you just have to keep going! I say this a lot but I really mean it, thank you everyone for the love and support.

Please share or donate to my GoFundMe:
https://www.gofundme.com/f/lets-help-andrew-in-the-fight-against-leukemia?utm_source=facebook&utm_medium=social&utm_campaign=p_cf+share-flow-1

Instagram:
https://www.instagram.com/_andrew_cawley_/

Facebook:
https://www.facebook.com/profile.php?id=100070819612478

Hairy Cell Leukemia Foundation:
https://www.hairycellleukemia.org/

#HairyCellLeukemia

Watch/Read More
Categories
Blood Cancer

Bone Marrow and Stem Cell Transplant Program Going Strong One Year Later | Sanford Health News [Video]

Chemotherapy can severely damage bone marrow in blood cancer patients. With autologous transplants, patients are their own bone marrow donors. The latest transplant patient, Donald Peterson of Bismarck, is recovering from a successful autologous bone marrow transplant procedure.The Sanford Roger Maris Cancer Center in Fargo, ND, has the state's first and only bone marrow transplant program.Learn more about blood and bone marrow transplant program: https://www.sanfordhealth.org/medical-services/cancer/blood-disorders-and-bone-marrow-transplantSubscribe for more stories: https://san.fo/2EuFiCY Visit our Sanford Health Facebook page: https://www.facebook.com/sanfordhealth/Follow us on Twitter: https://twitter.com/SanfordHealth Follow @SanfordHealth on Instagram: https://www.instagram.com/sanfordhealth/Connect with us on LinkedIn: linkedin.com/company/sanford-health/

Categories
Blood Cancer

CAR-T in multiple myeloma: cilta-cel & ide-cel [Video]

Nikhil Munshi, MD, Dana-Farber Cancer Institute, Boston, MA, shares his thoughts on how the addition of ciltacabtagene autoleucel (cilta-cel) and idecabtagene vicleucel (ide-cel) to the treatment paradigm is adding value to the treatment of patients with multiple myeloma. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.